Makary
Biotech

FDA stands behind decision to spurn mRNA flu filing

Following Moderna's public rebuke of the FDA's refusal to take up its application for a next-gen flu vaccine, the regulator has doubled down.
Warning symbol for radioactivity

Allogeneic CAR-T biotechs fight to escape 'nuclear winter'

Feb 11, 2026 11:00am
How AI Is reshaping clinical trials and market access

How AI Is reshaping clinical trials and market access

Feb 9, 2026 8:00am
liver

Madrigal pens $4.4B deal for siRNA drugs in fresh Rezdiffra play

Feb 11, 2026 7:40am
Article Primary Image 1jpg

The Data Multiplier Effect: The 4 Forces Changing Biometrics

Feb 9, 2026 8:00am
Moving van

Takeda consolidates Boston footprint

Feb 11, 2026 3:51pm
More News

Upstream posts Tezspire-like asthma efficacy in phase 2

Feb 11, 2026 7:24am

Moderna hit with FDA refusal-to-file letter for mRNA flu shot

Feb 10, 2026 7:45pm

Nektar eczema asset 'checked all of the boxes' in phase 2

Feb 10, 2026 10:55am

AstraZeneca's oral GLP-1 scored phase 2 wins, but no data yet

Feb 10, 2026 9:58am